Investment Centers of America’s Teva Pharmaceuticals TEVA Stock Holding History

Investment Centers of America’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-7,649	Closed	-$244K	–	650
2017 Q1	$244K	Buy	7,649 +1,450	+23%	+$49.5K	0.02%	521
2016 Q4	$226K	Buy	6,199 +1,550	+33%	+$61.9K	0.02%	522
2016 Q3	$214K	Buy	4,649 +144	+3%	+$7.51K	0.02%	473
2016 Q2	$226K	Sell	4,505 -992	-18%	-$52.8K	0.03%	427
2016 Q1	$293K	Buy	5,497 +760	+16%	+$44.6K	0.03%	363
2015 Q4	$313K	Buy	4,737 +582	+14%	+$36K	0.04%	321
2015 Q3	$233K	Buy	+4,155	New	+$269K	0.04%	366

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Investment Centers of America's TEVA Position: Q2 2017 in Review

Investment Centers of America sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 7,649 shares — an estimated $244K sold.

Investment Centers of America first reported a position in TEVA in Q3 2015 and held it in 7 quarters. The position peaked at $313K in Q4 2015. 649 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

Investment Centers of America reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
Investment Centers of America sold 7,649 Teva Pharmaceuticals shares in Q2 2017, an estimated $244K.
Investment Centers of America first reported a position in Teva Pharmaceuticals in Q3 2015 and held it in 7 quarters.
Investment Centers of America's Teva Pharmaceuticals position peaked at $313K in Q4 2015.
649 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Investment Centers of America's 13F filing for Q2 2017, filed 11 Aug 2017.